This document is an excerpt from the EUR-Lex website
Document 62025CN0044
Case C-44/25 P: Appeal brought on 23 January 2025 by Boehringer Ingelheim Pharma GmbH & Co. KG against the judgment of the General Court (Second Chamber) delivered on 13 November 2024 in Case T-524/23, Boehringer Ingelheim Pharma v EUIPO
Case C-44/25 P: Appeal brought on 23 January 2025 by Boehringer Ingelheim Pharma GmbH & Co. KG against the judgment of the General Court (Second Chamber) delivered on 13 November 2024 in Case T-524/23, Boehringer Ingelheim Pharma v EUIPO
Case C-44/25 P: Appeal brought on 23 January 2025 by Boehringer Ingelheim Pharma GmbH & Co. KG against the judgment of the General Court (Second Chamber) delivered on 13 November 2024 in Case T-524/23, Boehringer Ingelheim Pharma v EUIPO
OJ C, C/2025/5808, 10.11.2025, ELI: http://data.europa.eu/eli/C/2025/5808/oj (BG, ES, CS, DA, DE, ET, EL, EN, FR, GA, HR, IT, LV, LT, HU, MT, NL, PL, PT, RO, SK, SL, FI, SV)
|
Official Journal |
EN C series |
|
C/2025/5808 |
10.11.2025 |
Appeal brought on 23 January 2025 by Boehringer Ingelheim Pharma GmbH & Co. KG against the judgment of the General Court (Second Chamber) delivered on 13 November 2024 in Case T-524/23, Boehringer Ingelheim Pharma v EUIPO
(Case C-44/25 P)
(C/2025/5808)
Language of the case: English
Parties
Appellant: Boehringer Ingelheim Pharma GmbH & Co. KG (represented by: I. Fowler, abogada, C. Stöber, Rechtsanwältin)
Other party to the proceedings: European Union Intellectual Property Office
By order of 1 October 2025, The Court of Justice (Chamber determining whether appeals may proceed) held that the appeal was not allowed to proceed and that Boehringer Ingelheim Pharma GmbH & Co. KG shall bear its own costs.
ELI: http://data.europa.eu/eli/C/2025/5808/oj
ISSN 1977-091X (electronic edition)